Sander W Tas Selected Research

NF-kappa B (NF-kB)

6/2009	Gene therapy targeting nuclear factor-kappaB: towards clinical application in inflammatory diseases and cancer.
8/2006	Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5.
1/2006	Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sander W Tas Research Topics

Disease

18	Rheumatoid Arthritis 07/2023 - 01/2006
16	Inflammation (Inflammations) 01/2023 - 01/2006
11	Autoimmune Diseases (Autoimmune Disease) 11/2023 - 06/2009
9	COVID-19 07/2023 - 01/2021
7	Neoplasms (Cancer) 09/2022 - 06/2009
7	Arthritis (Polyarthritis) 01/2022 - 01/2006
6	Rheumatic Diseases (Rheumatism) 01/2024 - 08/2020
4	Infections 05/2024 - 01/2021
4	Breakthrough Infections 05/2024 - 06/2022
4	Multiple Sclerosis 03/2024 - 01/2022
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2023 - 10/2021
3	Crohn Disease (Crohn's Disease) 01/2024 - 01/2020
3	Synovitis 01/2023 - 04/2008
2	Drug-Related Side Effects and Adverse Reactions 01/2023 - 01/2021
2	Vasculitis (Vasculitides) 12/2021 - 10/2021
2	Atherosclerosis 01/2020 - 01/2018
2	Pathologic Neovascularization 01/2019 - 06/2018
2	Connective Tissue Diseases (Connective Tissue Disease) 01/2018 - 01/2018
2	Experimental Arthritis 08/2006 - 01/2006
1	Muscular Diseases (Myopathy) 01/2024
1	Post-Acute COVID-19 Syndrome 07/2023
1	Fatigue 07/2023
1	Axial Spondyloarthritis 01/2023
1	Psoriatic Arthritis 01/2023
1	AIDS-Related Complex (ARC) 06/2022
1	Spondylitis 01/2022
1	Osteitis 11/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hypersensitivity (Allergy) 01/2020

Drug/Important Bio-Agent (IBA)

6	AntibodiesIBA 05/2024 - 09/2015
6	Phosphotransferases (Kinase)IBA 01/2019 - 11/2014
5	Immunosuppressive Agents (Immunosuppressants)IBA 05/2024 - 01/2022
5	Etanercept (Enbrel)FDA Link 07/2023 - 08/2020
5	Immunomodulating AgentsIBA 05/2023 - 01/2015
5	Adalimumab (Humira)FDA Link 03/2023 - 01/2020
5	CytokinesIBA 12/2021 - 08/2006
4	AntigensIBA 07/2023 - 04/2008
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2023 - 01/2019
3	AutoantibodiesIBA 01/2024 - 09/2015
3	Rheumatoid FactorIBA 01/2024 - 09/2015
3	Rituximab (Mabthera)FDA Link 11/2023 - 01/2019
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 03/2023 - 01/2018
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2018
3	tocilizumab (atlizumab)FDA Link 01/2022 - 07/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Oxygen (Dioxygen)IBA 01/2022 - 02/2016
3	LipidsIBA 01/2020 - 07/2013
3	NF-kappa B (NF-kB)IBA 06/2009 - 01/2006
2	ocrelizumabIBA 03/2024 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2024 - 11/2021
2	Immunoglobulin M (IgM)IBA 01/2024 - 09/2015
2	COVID-19 VaccinesIBA 05/2022 - 11/2021
2	GlucocorticoidsIBA 01/2022 - 01/2021
2	Immunologic Factors (Immunomodulators)IBA 01/2022 - 01/2021
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2021 - 10/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2018
2	Peptides (Polypeptides)IBA 01/2019 - 01/2006
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2018 - 11/2014
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2015 - 01/2015
2	I-kappa B KinaseIBA 08/2006 - 01/2006
1	Monoclonal AntibodiesIBA 03/2024
1	HLA-DR Antigens (HLA-DR)IBA 03/2024
1	Messenger RNA (mRNA)IBA 03/2024
1	EpitopesIBA 01/2024
1	upadacitinibIBA 01/2024
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024
1	Infliximab (Remicade)FDA Link 07/2023
1	vedolizumabIBA 07/2023
1	Antiviral Agents (Antivirals)IBA 03/2023
1	AutoantigensIBA 01/2023
1	IgG Receptors (Fc gamma RI)IBA 01/2023
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	baricitinibIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Interleukin-1 (Interleukin 1)IBA 01/2022
1	Folate Receptor 2IBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022
1	tofacitinibIBA 01/2022
1	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022
1	Immunoglobulin A (IgA)IBA 11/2021
1	VaccinesIBA 11/2021
1	Methotrexate (Mexate)FDA LinkGeneric 11/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2021
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020
1	Interferon Type IIBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020

Therapy/Procedure

13	Therapeutics 11/2023 - 10/2015
2	Immunotherapy 09/2022 - 06/2009
2	Immunomodulation 01/2022 - 01/2021
2	Drug Therapy (Chemotherapy) 01/2020 - 06/2009
1	Transjugular Intrahepatic Portasystemic Shunt 01/2024
1	Injections 07/2023